Evidence map›Paper›PMID 20614134›Full record

ArticleJournal of cancer research and clinical oncology2011

Evidence of the cross talk between Wnt and Notch signaling pathways in non-small-cell lung cancer (NSCLC): Notch3-siRNA weakens the effect of LiCl on the cell cycle of NSCLC cell lines.

Chunyan Li, Ying Zhang, Yao Lu, Zeshi Cui, Miao Yu, Siyang Zhang, Xiaoxia Xue

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.Journal of cancer research and clinical oncology · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2013
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Chunyan LiCenter of Laboratory Technology and Experimental Medicine, China Medical University, 110001, Shenyang, People's Republic of China.
Ying Zhang
Yao Lu
Zeshi Cui
Miao Yu
Siyang Zhang
Xiaoxia Xue
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAberrant activations of Wnt and Notch signaling pathways are individually reported to be associated with the pathogenesis of non-small-cell lung cancer (NSCLC). However, the data about the cross talk between the two signaling pathways are still limited. To elucidate potential Wnt/Notch cross talk within NSCLC, we examined the impact of Notch3 activity on LiCl-induced cell cycle changes.

methodsThe lung cancer cell lines were treated with LiCl, a Wnt activator, in the absence or presence of Notch3-siRNA. Cell cycles and the expression of the regulators of cell cycle, c-MYC, p21 and Skp2 (S phase kinase-associated protein 2) were measured after treatment.

resultsThe treatment with LiCl increased the percent of cells at S phase and G phase and the expression of c-MYC and Skp2 and decreased the expression of p21. Moreover, the expression of Notch3 and its down-stream genes, HES-1 and HEYL, was up-regulated by LiCl. Notch3-siRNA weakened the effect of LiCl on the cell cycle and resulted in attenuation of the LiCl-induced increment of c-MYC and Skp2 and the LiCl-induced decrement of p21.

conclusionsThese data suggest that Notch3 activation cooperatively takes part in the LiCl-induced cell cycle changes, at least partially, associated with c-MYC, Skp2 and p21.

Indexed as

Carcinoma, Non-Small-Cell LungCell CycleCell Line, TumorCyclin-Dependent Kinase Inhibitor p21Glycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansLithium ChlorideProto-Oncogene Proteins c-mycReceptor, Notch3Receptors, NotchRNA, Small InterferingSignal TransductionS-Phase Kinase-Associated ProteinsWnt ProteinsCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21Glycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaLithium ChlorideMYC protein, humanNOTCH3 protein, humanProto-Oncogene Proteins c-mycReceptor, Notch3Receptors, NotchRNA, Small InterferingS-Phase Kinase-Associated ProteinsWnt Proteins

Identifiers

PMID20614134
PMCPMC11828197
OpenAlexW1972248567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.